Novel GLP-1 compounds

Details for Australian Patent Application No. 2004298424 (hide)

Owner Novo Nordisk A/S

Inventors Lau, Jesper; Madsen, Kjeld; Sturis, Jeppe; Johansen, Nils Langeland; Hansen, Thomas Kruse

Agent Shelston IP

Pub. Number AU-A-2004298424

PCT Pub. Number WO2005/058954

Priority PA 2004 01090 09.07.04 DK; PA 2003 01885 18.12.03 DK

Filing date 17 December 2004

Wipo publication date 30 June 2005

International Classifications

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/058954 Priority application(s): WO2005/058954

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298425-Novel GLP-1 analogues linked to albumin-like agents

2004298418-Reformer and method for reacting fuel and oxidant to reformate